Role of host protein GBF1 in organizing enterovirus replication complexes
宿主蛋白 GBF1 在组织肠道病毒复制复合体中的作用
基本信息
- 批准号:9295959
- 负责人:
- 金额:$ 37.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-14 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:Alpha CellAntiviral AgentsAntsAsthmaBiologyBiotinBrefeldin ACarrier ProteinsCell physiologyCellsCellular MembraneChronicClinicalCollaborationsCommon ColdComplexCoxsackie VirusesDataDevelopmentDisease OutbreaksEncephalitisEnsureEnterovirusEnterovirus 68Enterovirus 71FDA approvedFamilyFamily PicornaviridaeFoundationsFrequenciesGBF1 geneGenetic VariationGenomeGolgi ApparatusGuanine Nucleotide Exchange FactorsGuanosine TriphosphateGuanosine Triphosphate PhosphohydrolasesHeartHumanHuman poliovirusIn VitroInsulin-Dependent Diabetes MellitusIntegration Host FactorsInterventionKnowledgeLabelLife Cycle StagesLigaseLipidsLungMacromolecular ComplexesMediatingMedicalMembraneMembrane Protein TrafficMetabolic PathwayMetabolismModelingMolecularMolecular and Cellular BiologyMonomeric GTP-Binding ProteinsMutationMyocarditisMyopathyNeurologicObstructionOrganellesParasitesPathogenicityPathway interactionsPharmaceutical PreparationsPoliomyelitisProcessProteinsPublic HealthRNA VirusesRecruitment ActivityResearchResistanceResistance developmentResolutionRhinovirusRoleSmall RNAStructureSyndromeSystemTechniquesTertiary Protein StructureTherapeuticTranslationsUnited StatesVaccinationVaccinesVertebrate VirusesViralViral ProteinsVirusVirus AssemblyVirus DiseasesVirus Replicationdrug developmentgenetic resourcehuman diseasein vivonovelnovel strategiesnovel therapeutic interventionoverexpressionpathogenpressureprotein functionprotein transportscaffoldtherapeutic targettrafficking
项目摘要
Description of the project. Viruses are the ultimate intracellular parasites. With minimal genetic
resources they are able to reroute cellular metabolic pathways and hijack cellular proteins to promote
their own replication. Thus, understanding the role of specific host factors in the viral life cycle is essential
for the development of novel anti-viral strategies. Enteroviruses are a group of picornaviruses, small
+RNA viruses of vertebrates including humans. Enteroviruses cause clinically and economically
important human diseases, ranging from the common cold to fatal encephalitis and myocarditis. High
genetic diversity and adaptability of these viruses complicates development of comprehensive vaccines
and traditional therapeutics targeting virus-specific proteins. Of all the pathogenic enteroviruses, only
polioviruses can be controlled with vaccines, and no clinically approved anti-enterovirus drugs are
available. Thus, novel approaches are urgently needed to control enteroviruses associated with human
diseases. Picornaviruses replicate their genomes on specialized membrane domains, replication
organelles that feature unique lipid and protein composition and whose development relies on the re-
organization of cellular lipid synthesis and membrane trafficking pathways. This implies that at least some
cellular membrane metabolism components must be indispensable for viral propagation. Indeed,
enteroviruses universally require the host protein GBF1 for their replication. GBF1 is a large multi-domain
protein that functions as a guanine nucleotide exchange factor (GEF) for select small GTPases of the Arf
family. GBF1 is a master coordinator of the early steps of protein transport in the secretory pathway, and
participates in maintaining Golgi structure and function and in lipid droplet metabolism. However, how
GBF1 supports the viral replication cycle remains unknown. Attempts to relate the known cellular
activities of GBF1 such as Arf activation, membrane remodeling and recruitment of cellular proteins to
membranes to GBF1 function in viral replication produced controversial results. GBF1 is known to interact
with numerous cellular proteins and with the enterovirus replication protein 3A, but how viruses use these
interactions to their advantage remains unknown. Herein, we propose a new model in which GBF1 acts
as a molecular scaffold to coordinate the assembly of viral and cellular proteins into operational replication
complexes. For this project, we built a team of a cell biologist with a superior expertise in GBF1 biology
(Sztul), and a virologist with an outstanding background in picornavirus replication (Belov). Together, we
will delineate the step(s) in viral life cycle that require GBF1 and uncover the mechanisms of GBF1 action
in the formation function of replication complexes. The universal reliance of diverse enteroviruses on
GBF1 provides an unprecedented opportunity for the development of broad-spectrum therapeutics
targeting GBF1-controlled processes in infected cells.
项目的描述。病毒是最终的细胞内寄生虫。遗传最小
他们能够重新布鲁特的细胞代谢途径和劫持蜂窝蛋白来促进
他们自己的复制。因此,了解特定宿主因素在病毒生命周期中的作用是必不可少的
为了制定新型的反病毒策略。肠病毒是一组Picornaviruses,小
+包括人类在内的脊椎动物的RNA病毒。肠病毒在临床和经济上引起
重要的人类疾病,范围从普通的冷脑炎和心肌炎。高的
这些病毒的遗传多样性和适应性使综合疫苗的开发变得复杂
以及针对病毒特异性蛋白质的传统治疗剂。在所有病原肠病毒中,仅
脊髓灰质炎病毒可以用疫苗控制,并且没有临床批准的抗肠病毒药物是
可用的。因此,迫切需要新的方法来控制与人相关的肠病毒
疾病。 Picornaviruses在专门的膜域上复制其基因组,复制
具有独特脂质和蛋白质组成的细胞器,其发育依赖于重新
细胞脂质合成和膜运输途径的组织。这意味着至少有一些
细胞膜代谢成分对于病毒传播必须是必不可少的。的确,
肠病毒普遍要求宿主蛋白GBF1复制。 GBF1是一个大型多域
作为选择ARF的小GTPase的鸟嘌呤核苷酸交换因子(GEF)的蛋白质
家庭。 GBF1是分泌途径中蛋白质运输早期步骤的总协调员,
参与维持高尔基体的结构和功能以及脂质液滴代谢。但是,如何
GBF1支持病毒复制周期仍然未知。尝试关联已知细胞的尝试
GBF1的活性,例如ARF激活,膜重塑和细胞蛋白的募集到
在病毒复制中,gbf1功能的膜产生了有争议的结果。已知GBF1相互作用
具有许多细胞蛋白和肠病毒复制蛋白3a,但是病毒如何使用这些
为了他们的优势,互动仍然未知。在此,我们提出了一个新模型,其中GBF1行动
作为分子支架,以将病毒和细胞蛋白的组装成量复制
复合物。对于这个项目,我们建立了一个细胞生物学家的团队,具有GBF1生物学领域的卓越专业知识
(sztul),以及具有Picornavirus Replication(Belov)背景下杰出背景的病毒学家。在一起,我们
将在需要GBF1的病毒生命周期中描述步骤,并揭示GBF1动作的机制
在复制复合物的形成函数中。各种肠病毒的普遍依赖
GBF1为开发广谱疗法提供了前所未有的机会
靶向受感染细胞中的GBF1控制过程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
George A. Belov其他文献
George A. Belov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('George A. Belov', 18)}}的其他基金
Infection-specific lipid metabolism as a target to control enterovirus infections
感染特异性脂质代谢作为控制肠道病毒感染的目标
- 批准号:
10450249 - 财政年份:2022
- 资助金额:
$ 37.38万 - 项目类别:
Infection-specific lipid metabolism as a target to control enterovirus infections
感染特异性脂质代谢作为控制肠道病毒感染的目标
- 批准号:
10597236 - 财政年份:2022
- 资助金额:
$ 37.38万 - 项目类别:
Refocusing the immune response from structural to conserved non-structural proteins as a novel vaccination approach for inducing broad anti-enterovirus protection
将免疫反应从结构蛋白重新聚焦到保守的非结构蛋白,作为诱导广泛抗肠道病毒保护的新型疫苗接种方法
- 批准号:
10041960 - 财政年份:2020
- 资助金额:
$ 37.38万 - 项目类别:
Refocusing the immune response from structural to conserved non-structural proteins as a novel vaccination approach for inducing broad anti-enterovirus protection
将免疫反应从结构蛋白重新聚焦到保守的非结构蛋白,作为诱导广泛抗肠道病毒保护的新型疫苗接种方法
- 批准号:
10254302 - 财政年份:2020
- 资助金额:
$ 37.38万 - 项目类别:
Role of host protein GBF1 in organizing enterovirus replication complexes
宿主蛋白 GBF1 在组织肠道病毒复制复合体中的作用
- 批准号:
9158557 - 财政年份:2016
- 资助金额:
$ 37.38万 - 项目类别:
相似国自然基金
核苷类抗病毒药物嵌合型核酸纳米载体的构筑及其抗病毒性能研究
- 批准号:52303174
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
水环境中抗病毒药物及其转化副产物的识别及生态毒性效应研究
- 批准号:52300245
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向病毒核衣壳蛋白质相分离的抗病毒药物发现及机制研究
- 批准号:82302491
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
天然/合成有机质结合态抗病毒药物的迁移特性和界面行为
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
分区耦合式三电子氧还原高级氧化系统处理核苷类抗病毒药物废水及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesis
I 型干扰素在调节 COVID-19 诱导的炎症和发病机制中的作用
- 批准号:
10321484 - 财政年份:2020
- 资助金额:
$ 37.38万 - 项目类别:
Development of prodrug approaches for long-acting nanoformulations of emtricitabine-based regimens
开发基于恩曲他滨的方案的长效纳米制剂的前药方法
- 批准号:
9410823 - 财政年份:2017
- 资助金额:
$ 37.38万 - 项目类别:
Role of host protein GBF1 in organizing enterovirus replication complexes
宿主蛋白 GBF1 在组织肠道病毒复制复合体中的作用
- 批准号:
9158557 - 财政年份:2016
- 资助金额:
$ 37.38万 - 项目类别:
STRUCTURAL STUDIES OF YEAST RIBONUCLEOTIDE REDUCTASE, AMYLOID-RECOGNIZING ANT
酵母核糖核苷酸还原酶、淀粉样蛋白识别蚂蚁的结构研究
- 批准号:
7956850 - 财政年份:2009
- 资助金额:
$ 37.38万 - 项目类别:
NASAL DNA/PROTEIN VACCINE FOR ANTI-HIV ANTIBODY AND CTL
用于抗 HIV 抗体和 CTL 的鼻 DNA/蛋白疫苗
- 批准号:
7916232 - 财政年份:2009
- 资助金额:
$ 37.38万 - 项目类别: